259 related articles for article (PubMed ID: 20924615)
1. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.
Kurokawa S; Katsuki S; Fujita T; Saitoh Y; Ohta H; Nishikawa K; Sato Y; Sato Y; Ohira K; Yamada M; Kato M
J Gastroenterol; 2014 Feb; 49(2):239-44. PubMed ID: 23595613
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
Mizukami K; Murakami K; Abe T; Inoue K; Uchida M; Okimoto T; Kodama M; Fujioka T
World J Gastroenterol; 2011 Dec; 17(46):5117-22. PubMed ID: 22171147
[TBL] [Abstract][Full Text] [Related]
5. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
Fujimori S; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Gastrointest Endosc; 2009 Jun; 69(7):1339-46. PubMed ID: 19243767
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.
Watanabe T; Takeuchi T; Handa O; Sakata Y; Tanigawa T; Shiba M; Naito Y; Higuchi K; Fujimoto K; Yoshikawa T; Arakawa T
PLoS One; 2015; 10(4):e0122330. PubMed ID: 25874951
[TBL] [Abstract][Full Text] [Related]
7. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.
Kuramoto T; Umegaki E; Nouda S; Narabayashi K; Kojima Y; Yoda Y; Ishida K; Kawakami K; Abe Y; Takeuchi T; Inoue T; Murano M; Tokioka S; Higuchi K
BMC Gastroenterol; 2013 May; 13():85. PubMed ID: 23672202
[TBL] [Abstract][Full Text] [Related]
9. Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury.
Huang C; Lu B; Fan YH; Zhang L; Jiang N; Zhang S; Meng LN
World J Gastroenterol; 2014 Aug; 20(31):11012-8. PubMed ID: 25152605
[TBL] [Abstract][Full Text] [Related]
10. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
[TBL] [Abstract][Full Text] [Related]
11. Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
Wood RC; Wyatt JE; Bullins KW; Hanley AV; Hanley GA; Denham JW; Panus PC; Harirforoosh S
Eur J Pharmacol; 2013 Nov; 720(1-3):138-46. PubMed ID: 24365796
[TBL] [Abstract][Full Text] [Related]
12. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
Xu N; Zhang C; Jing L; Mou S; Cao X; Yu Z
Int Immunopharmacol; 2021 Jan; 90():107136. PubMed ID: 33218942
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: a prospective randomized study.
Xiong L; Huang X; Li L; Yang X; Liang L; Zhan Z; Ye Y; Chen M
Dig Liver Dis; 2015 Apr; 47(4):280-4. PubMed ID: 25660821
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers.
Kim HK; Kim JI; Kim JK; Han JY; Park SH; Choi KY; Chung IS
Dig Dis Sci; 2007 Aug; 52(8):1776-82. PubMed ID: 17410467
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.
Umegaki E; Kuramoto T; Kojima Y; Nouda S; Ishida K; Takeuchi T; Inoue T; Tokioka S; Higuchi K
Intern Med; 2014; 53(4):283-90. PubMed ID: 24531083
[TBL] [Abstract][Full Text] [Related]
16. Distribution of small intestinal mucosal injuries as a result of NSAID administration.
Fujimori S; Gudis K; Takahashi Y; Seo T; Yamada Y; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Eur J Clin Invest; 2010 Jun; 40(6):504-10. PubMed ID: 20412292
[TBL] [Abstract][Full Text] [Related]
17. Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs.
Isomura Y; Yamaji Y; Yamada A; Watanabe Y; Suzuki H; Kobayashi Y; Yoshida S; Watabe H; Hirata Y; Yoshida H; Koike K
Gastrointest Endosc; 2014 Jul; 80(1):118-25. PubMed ID: 24518124
[TBL] [Abstract][Full Text] [Related]
18. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
[TBL] [Abstract][Full Text] [Related]
19. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota.
Tanigawa T; Watanabe T; Higashimori A; Shimada S; Kitamura H; Kuzumoto T; Nadatani Y; Otani K; Fukunaga S; Hosomi S; Tanaka F; Kamata N; Nagami Y; Taira K; Shiba M; Suda W; Hattori M; Fujiwara Y
PLoS One; 2021; 16(1):e0245995. PubMed ID: 33507971
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.
Scarpignato C; Dolak W; Lanas A; Matzneller P; Renzulli C; Grimaldi M; Zeitlinger M; Bjarnason I
Gastroenterology; 2017 Apr; 152(5):980-982.e3. PubMed ID: 28007576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
